{
    "nctId": "NCT03139435",
    "briefTitle": "Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer",
    "officialTitle": "A Pilot Study Using Ultrasound for the Detection of Taxane-Induced Peripheral Neuropathy",
    "overallStatus": "COMPLETED",
    "conditions": "Peripheral Neuropathy, Stage 0 Breast Cancer, Stage I Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 20,
    "primaryOutcomeMeasure": "Tibial Nerve Cross-sectional Area",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer (any stage)\n* Previously or currently receiving taxane-based chemotherapy\n* Clinical symptoms of peripheral neuropathy noted in medical record and suspected to be secondary to taxane-based therapy\n* Ability and willingness to understand and sign an informed consent\n\nExclusion Criteria:\n\n* Self-reported or documented history of pre-existing peripheral neuropathy prior to initiation of taxane chemotherapy\n* Unable to provide history",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}